English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 24 August 2023, 08:30 HKT/SGT
Share:
Global New Material International Announced the Completion of the Acquisition of CQV

HONG KONG, CHINA, Aug 24, 2023 - (ACN Newswire) - On August 23, 2023, Global New Material International Holdings Limited (the "Company", stock code: 6616.HK) announced that it completed the acquisition of certain CQV shares and all CQV treasury shares.

The Company announced that all conditions precedent under the each of the CQV Sale Shares Agreements and the CQV Treasury Shares Agreement have been satisfied and the Closing took place on 22 August 2023.

Upon the Closing, the Company holds 42.45% of the issued shares of CQV and is the single largest shareholder of CQV. CQV has become a non-wholly owned subsidiary of the Company with the financial performance and position to be consolidated into the accounts of the Group.

As part of the Closing, the Company has allotted and issued an aggregate of 47,106,546 Consideration Shares at the Issue Price to CQV Vendors and CQV. The Consideration Shares, representing 3.81% of the total number of the Shares in issue as enlarged by the Consideration Shares, rank pari passu with the existing Shares in issue.

The Directors believe that the Acquisition offers a good chance for the Group to tap on opportunities in and expand its business presence in the international pearlescent pigments industry.

The Acquisition is also consistent with the Group's business strategy and could enhance the synergy between CQV and the Group. Through the acquisition and control of CQV, the Group can leverage on the experience, know-how and market presence of CQV, increase its market share, enhance its product offerings and thereby increase the overall competitiveness of the Group.

About Global New Material International Holdings LTD.
Global New Material International Holdings Limited, a company incorporated in the Cayman Islands with limited liability, the Shares of which are listed on the Main Board of the Hong Kong Stock Exchange (stock code: 06616.HK). The Group is principally engaged in the business of production and sales of pearlescent pigment products and synthetic mica powder in the PRC. It provides more than 950 different types of products used in industrial, exterior and cosmetic applications. The Company is known as the largest pearlescent pigment producer in China and the fourth largest globally based on 2021 revenue.

About CQV Co., Ltd.
CQV is a company incorporated in the Republic of Korea with limited liability on 20 October 2000 with its common shares listed on KOSDAQ (KOSDAQ: 101240). CQV is principally engaged in the production and sales of pearlescent pigments in the Republic of Korea. CQV has developed world-leading synthetic mica product offers and mature technology to produce high-end pearlescent materials applied in industrial, automotive and cosmetic sectors.


Topic: Press release summary Sectors: Chemicals, Spec.Chem
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Maxon One Winter Release Brings Holiday Cheer from Concept to Render  
Dec 5, 2024 00:00 HKT/SGT
Autobrains and JOYNEXT Revolutionize Smart Camera Solution Powered by Autobrains' Affordable Safety ADAS Software  
Dec 4, 2024 22:20 HKT/SGT
CITIC Telecom CPC's Internal and External Cybersecurity Excellence Honored with 3 Industry Awards  
Dec 4, 2024 22:10 HKT/SGT
Naoris Protocol announces World's First Post-Quantum DePIN for Cybersecurity & Digital Trust ahead of Testnet  
Dec 4, 2024 21:26 HKT/SGT
25th Hong Kong Forum concludes successfully  
Dec 4, 2024 21:00 HKT/SGT
DENSO Signs Memorandum of Understanding with Canatu of Finland for Practical Application of Carbon Nanotube Technology  
Wednesday, December 4, 2024 4:51:00 PM
Sweetness Affecting Both the Young and Old: Prevent Diabetes with LAC This World Diabetes Day  
Dec 4, 2024 14:30 HKT/SGT
Everest Medicines Announces Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of Primary Membranous Nephropathy  
Dec 4, 2024 11:08 HKT/SGT
DeAgentAI and OKX Wallet Join Forces: $50K DA Token Airdrop for Web3 Enthusiasts  
Dec 4, 2024 09:45 HKT/SGT
Japan Maritime Defense Force Selects SeaGuardians From GA-ASI  
Dec 4, 2024 08:00 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575